超声内镜引导下胃空肠吻合术与外科胃空肠吻合术姑息治疗恶性胃出口梗阻的比较(ENDURO):随机对照试验研究方案
ENDURO为多中心、开放标签、平行组随机对照试验,计划纳入96例不可切除或转移性恶性肿瘤所致胃出口梗阻患者,1:1随机接受外科胃空肠吻合术(SGJ)或超声内镜引导下胃空肠吻合术(EUS-GE)。共同主要终点为耐受至少软食的时间及因持续或复发梗阻症状需再干预的患者比例,旨在比较两种姑息治疗方式的疗效、安全性与费用。
要点
- ENDURO为多中心开放标签随机对照试验,计划纳入96例恶性胃出口梗阻患者。
- 患者1:1随机接受SGJ或EUS-GE,比较疗效、安全性与费用。
- 共同主要终点为耐受至少软食时间及因持续或复发梗阻需再干预比例。
核心结论
- ENDURO研究评估EUS-GE相较SGJ能否更快恢复固体经口进食,并在持续或复发梗阻症状再干预方面非劣效。
- 该试验旨在指导未来治疗策略并改善姑息治疗场景下的生活质量。
研究设计与样本
- 多中心、开放标签、平行组随机对照试验。
- 计划纳入96例由不可切除或转移性恶性肿瘤所致胃出口梗阻患者,1:1随机分配至SGJ组或EUS-GE组。
主要发现
- 主要终点为耐受至少软食的时间。
- 共同主要终点为因持续或复发胃出口梗阻症状需再干预的患者比例。
- 次要终点包括技术成功与临床成功、生活质量、胃空肠吻合功能障碍、再干预、再干预时间、不良事件、开始化疗时间、住院时长、再入院、体重、生存与费用。
关键数值与推荐
- 试验注册:国际临床试验注册平台(ICTRP)NL9592,注册日期2021年7月7日。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malignant gastric outlet obstruction (GOO) is a debilitating condition that frequently occurs in patients with malignancies of the distal stomach and (peri)ampullary region. The standard palliative treatment for patients with a reasonable life expectancy and adequate performance status is a laparoscopic surgical gastrojejunostomy (SGJ). Recently, endoscopic ultrasound-guided gastroenterostomy (EUS-GE) emerged as a promising alternative to the surgical approach. The present study aims to compare these treatment modalities in terms of efficacy, safety, and costs. METHODS: The ENDURO-study is a multicentre, open-label, parallel-group randomized controlled trial. In total, ninety-six patients with gastric outlet obstruction caused by an irresectable or metastasized malignancy will be 1:1 randomized to either SGJ or EUS-GE. The primary endpoint is time to tolerate at least soft solids. The co-primary endpoint is the proportion of patients with persisting or recurring symptoms of gastric outlet obstruction for which a reintervention is required. Secondary endpoints are technical and clinical success, quality of life, gastroenterostomy dysfunction, reinterventions, time to reintervention, adverse events, quality of life, time to start chemotherapy, length of hospital stay, readmissions, weight, survival, and costs. DISCUSSION: The ENDURO-study assesses whether EUS-GE, as compared to SGJ, results in a faster resumption of solid oral intake and is non-inferior regarding reinterventions for persistent or recurrent obstructive symptoms in patients with malignant GOO. This trial aims to guide future treatment strategies and to improve quality of life in a palliative setting. TRIAL REGISTRATION: International Clinical Trials Registry Platform (ICTRP): NL9592. Registered on 07 July 2021.
引用
- Kastelijn JB, van de Pavert YL, Besselink MG, et al. Endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for palliation of malignant gastric outlet obstruction (ENDURO): study protocol for a randomized controlled trial. Trials. 2023. PMID: 37749590. doi:10.1186/s13063-023-07522-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。